Quantity size:
0.2ml
Concentration:
1mg/ml 磷酸化桩蛋白Paxillin抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Paxillin is a 64 kDa cytoskeletal adapter protein involved in organisation and function of focal adhesions, which are critical to cell adhesion and migration. This in turn plays a role in a wide variety of processes including embryogenesis, organogenesis, wound repair,磷酸化桩蛋白Paxillin抗体 inflammation and cancer. Paxillin contains LD motifs, LIM domains, SH3 and SH2 binding domains that serve as docking sites for cytoskeletal proteins, tyrosine kinases (e.g., FAK, Pyk 2, Src), serine/threonine kinases, GTPase activating proteins and other adaptor proteins (e.g., Actin, Vinculin, Crk).
磷酸化桩蛋白Paxillin抗体Also known as:
PXN(phospho S83); Paxillin (phospho S83); Paxillin (phospho Ser83); p-Paxillin (Ser83); Paired box protein Pax 1; PAX 1; PAX1; Paxillin alpha; PXN; PXN protein; FLJ16691; FLJ23042; FLJ16691; PAXI_HUMAN; Paxillin; PXN protein.
Specificity:
●
Rabbit Polyclonal IgG,磷酸化桩蛋白Paxillin抗体 affinity purified by Protein A.
●
Reacts with: Human, Cow, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Phospho-Paxillin(Ser83).
●
磷酸化桩蛋白Paxillin抗体Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
kl134Ca01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Hu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Mu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Po01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ra01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Rb51肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Si01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl135Bo01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ca01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ga01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Hu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Mu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Po01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ra01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl139Ca01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Hu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Mu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Ra01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl140Bo01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Ga01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Hu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Mu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
Optimal working dilutions must be determined by the end user.
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话